Brent Gurney has significant jury trial and other court experience in complex civil and criminal cases throughout the United States.
Among Mr. Gurney's substantial jury trials are the recent representation of the former chief accounting officer of a national homebuilder facing federal conspiracy, securities and obstruction charges, and the defense of a former regional manager for a medical device manufacturer who was alleged to have participated in a fraudulent off-label marketing scheme. In that case, Mr. Gurney obtained a complete dismissal of all charges following opening statements and testimony from the government's first witness. AmericanLawyer.com called the dismissal "quite the dramatic turn." The dismissal was one of five cases featured in "Winning," the National Law Journal's annual report on significant trial victories. (National Law Journal/www.nlj.com, "Winning," March 12, 2012.)
Mr. Gurney's significant jury trials also include the jury verdict for IGEN that allowed it to terminate its licensing agreement with Roche, IGEN's key business objective, and awarded $505 million in damages. The US Court of Appeals for the Fourth Circuit sustained the termination right, after which Roche purchased IGEN in a $1.25 billion deal. The $505 million jury verdict, which the Fourth Circuit reduced, ranks fourth in the National Law Journal's top verdicts of 2002.
In addition, Mr. Gurney has counseled and represented clients on issues including commercial construction disputes, trade secret misappropriation, copyright infringement, healthcare fraud, and the attorney client privilege. He has also handled numerous sensitive internal investigations into a wide variety of financial and other matters for clients in the US, Europe, Africa, South America, Asia and the Middle East.
Mr. Gurney previously served as Assistant US Attorney in the US Attorney's Office for the District of Maryland, and was later appointed Deputy Chief for the Southern Division. Mr. Gurney prosecuted, conducted and oversaw grand jury investigations involving money laundering, healthcare fraud, bank fraud, credit card fraud, mail fraud, wire fraud, government contracts fraud, federal income tax evasion, violent crime, narcotics, the Food, Drug & Cosmetics Act, and asset forfeiture.
